The Health Economics and Patient Value (HEPV) initiative at the Medical Device Innovation Consortium (MDIC), in collaboration with Edwards Lifesciences, has released a timely and impactful new resource: How Can Medical Device Manufacturers Make Best Use of Patient Preference Information?
There is a growing need for real world evidence (RWE) and patient perspectives when bringing new pharmaceuticals and medical technologies to market. An emerging metric in the RWE arena is patient preference information, which can provide supplemental data that empowers device manufacturers to demonstrate value and meet expectations of regulators, payers, hospitals, and patients. As defined in the introduction to our new case study, “Patient preference information captures the value that patients place on aspects of a treatment option, while also accounting for their perspectives on trade-offs they are willing to make for the benefits and risks that come with the treatment.”
Explore the new resource from MDIC, with development support from Edwards Lifesciences: How Can Medical Device Manufacturers Make Best Use of Patient Preference Information? to better understand how patient preference information can best be utilized by key stakeholders throughout the healthcare ecosystem, including: manufacturers tailoring existing products in order to improve patients’ experience; regulators making approval determinations informed by patients’ input; payers evaluating coverage decisions through a lens that brings more value to patients; and patients having the opportunity to gain access to new technologies faster, empowered to express their decisions on what the right treatment is for them.
